| Angiotensin-converting enzyme 2 and renal disease |
16 |
| An update on predicting renal progression in IgA nephropathy |
13 |
| Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease |
13 |
| Methylglyoxal stress, the glyoxalase system, and diabetic chronic kidney disease |
12 |
| The gut microbiota and blood pressure in experimental models |
12 |
| Gender differences in hypertension |
11 |
| Sex hormones and their influence on chronic kidney disease |
11 |
| Unmet challenges in membranous nephropathy |
10 |
| The systems biology of uric acid transporters: the role of remote sensing and signaling |
10 |
| Recent advances in acute kidney injury and its consequences and impact on chronic kidney disease |
8 |
| Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease |
8 |
| The case for cautious consumption: NSAIDs in chronic kidney disease |
8 |
| Activin receptor ligand traps in chronic kidney disease |
6 |
| Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus |
6 |
| Hemodialysis versus peritoneal dialysis in resource-limited settings |
6 |
| Diagnosis of monogenic chronic kidney diseases |
6 |
| Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response |
6 |
| The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease |
6 |
| Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug |
6 |
| Chronic kidney disease and acquired mitochondrial myopathy |
6 |
| Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts |
5 |
| Source and microenvironmental regulation of erythropoietin in the kidney |
5 |
| Fluid status assessment in hemodialysis patients and the association with outcome: review of recent literature |
5 |
| Acute kidney injury prediction models: current concepts and future strategies |
5 |
| The role of toll-like receptors in diabetic kidney disease |
5 |
| Bile acid receptors and the kidney |
5 |
| An overview of the mechanisms in vascular calcification during chronic kidney disease |
5 |
| Hypoxia, hypoxia-inducible transcription factors and oxygen-sensing prolyl hydroxylases in bone development and homeostasis |
5 |
| New insights regarding epithelial Na+ channel regulation and its role in the kidney, immune system and vasculature |
5 |
| Urgent start peritoneal dialysis |
5 |
| The use of bioimpedance spectroscopy to guide fluid management in patients receiving dialysis |
5 |
| The Drosophila Malpighian tubule as a model for mammalian tubule function |
4 |
| Hyponatremia in patients with cancer |
4 |
| Epithelial sodium channel biogenesis and quality control in the early secretory pathway |
4 |
| Distal tubule basolateral potassium channels: cellular and molecular mechanisms of regulation |
4 |
| Impact of gender and gender disparities in patients with kidney disease |
4 |
| Beginnings of nephrolithiasis: insights into the past, present and future of Randall's plaque formation research |
4 |
| The pivotal role of renal vasodysfunction in salt sensitivity and the initiation of salt-induced hypertension |
4 |
| Evolving complexity of complement-related diseases: C3 glomerulopathy and atypical haemolytic uremic syndrome |
3 |
| Leave no stone unturned: defining recurrence in kidney stone formers |
3 |
| Atypical hemolytic uremic syndrome and complement blockade: established and emerging uses of complement inhibition |
3 |
| alpha-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent |
3 |
| Claudins and nephrolithiasis |
3 |
| Retarding progression of chronic kidney disease: use of modalities that counter acid retention |
3 |
| Citrate therapy for calcium phosphate stones |
3 |
| Novel therapeutic strategies for renovascular disease |
3 |
| Intracellular chloride: a regulator of transepithelial transport in the distal nephron |
3 |
| Enteric hyperoxaluria: role of microbiota and antibiotics |
3 |
| Magnesium and calciprotein particles in vascular calcification: the good cop and the bad cop |
3 |
| Bone and heart health in chronic kidney disease: role of dentin matrix protein 1 |
3 |
